| Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report P Horby, WS Lim, J Emberson, M Mafham, J Bell, L Linsell, N Staplin, ... MedRxiv, 2020.06. 22.20137273, 2020 | 12556* | 2020 |
| ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ... Bmj 369, m1985, 2020 | 3828* | 2020 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2954 | 2020 |
| An atlas of active enhancers across human cell types and tissues R Andersson, C Gebhard, I Miguel-Escalada, I Hoof, J Bornholdt, M Boyd, ... Nature 507 (7493), 455-461, 2014 | 2798 | 2014 |
| Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury CD Russell, JE Millar, JK Baillie The lancet 395 (10223), 473-475, 2020 | 2539 | 2020 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 1811 | 2021 |
| A promoter-level mammalian expression atlas Nature 507 (7493), 462-470, 2014 | 1808 | 2014 |
| Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1561 | 2020 |
| Genetic mechanisms of critical illness in COVID-19 E Pairo-Castineira, S Clohisey, L Klaric, AD Bretherick, K Rawlik, D Pasko, ... Nature 591 (7848), 92-98, 2021 | 1459 | 2021 |
| The 2018 Lake Louise acute mountain sickness score RC Roach, PH Hackett, O Oelz, P Bärtsch, AM Luks, MJ MacInnis, ... High altitude medicine & biology 19 (1), 4-6, 2018 | 1451 | 2018 |
| Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ... Nature immunology 21 (11), 1336-1345, 2020 | 1324 | 2020 |
| The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and … J Mair-Jenkins, M Saavedra-Campos, JK Baillie, P Cleary, FM Khaw, ... The Journal of infectious diseases 211 (1), 80-90, 2015 | 1248 | 2015 |
| Microglial brain region− dependent diversity and selective regional sensitivities to aging K Grabert, T Michoel, MH Karavolos, S Clohisey, JK Baillie, MP Stevens, ... Nature neuroscience 19 (3), 504-516, 2016 | 1210 | 2016 |
| A minimal common outcome measure set for COVID-19 clinical research JC Marshall, S Murthy, J Diaz, NK Adhikari, DC Angus, YM Arabi, K Baillie, ... The lancet infectious diseases 20 (8), e192-e197, 2020 | 1193 | 2020 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1149 | 2021 |
| Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ... bmj 370, 2020 | 1113 | 2020 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 1023 | 2022 |
| Gateways to the FANTOM5 promoter level mammalian expression atlas M Lizio, J Harshbarger, H Shimoji, J Severin, T Kasukawa, S Sahin, ... Genome biology 16, 1-14, 2015 | 920 | 2015 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 887 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 878 | 2021 |
Malcolm G SempleProfessor of Child Health and Outbreak Medicine, University of Liverpoolliverpool.ac.uk의 이메일 확인됨
